PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1392013
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1392013
Global impingement syndrome market size is estimated to value at US$ 1,380.4 million in 2023 and is expected to reach US$ 2,224 million by 2030, exhibiting a compound annual growth rate (CAGR) of 7% from 2023 to 2030.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 1,380.4 Mn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: | 7.00% | 2030 Value Projection: | US$ 2,224 Mn |
Impingement syndrome refers to the narrowing of the subacromial space which leading to impingement of the tendons of the rotator cuff muscles. It is a condition in which the tendons of the rotator cuff of the shoulder are pinched as they pass between the top of the upper arm (humerus) and the tip of the shoulder (acromion). Impingement syndrome treatment can range from simple home treatment such as aspirin and rest to surgery, depending on how severe the impingement is. Impingement syndrome, also known as shoulder impingement, is a condition where the tendons of the rotator cuff muscles become compressed. This happens when these tendons pass through a narrow bony space in the shoulder called the subacromial space. The pressure on these tendons can cause pain and discomfort, especially when lifting the arm. Impingement syndrome can be caused by repetitive arm movements or overhead activities, which can lead to swelling and inflammation of the rotator cuff tendons. This is common in sports that require a lot of overhead movements like tennis, swimming, or weightlifting, and jobs that require repetitive arm movements. Symptoms of impingement syndrome include persistent pain in the shoulder, pain that worsens at night, and difficulty reaching up behind the back. Pain may also occur when lifting the arm overhead or while throwing a ball. Treatment for impingement syndrome often involves physical therapy, non-steroidal anti-inflammatory drugs (NSAIDs), and corticosteroid injections. In severe cases, surgery may be required.
Increasing prevalence of musculoskeletal disorders, growing geriatric population, and rise in demand for safe & effective treatment, and increasing research and development are major factors expected to drive the growth of the global impingement syndrome market.
For instance, according to the World Health Organization (WHO), in July 2022, around 1.71 billion people across the globe worldwide have musculoskeletal conditions. Musculoskeletal conditions are the leading contributor to disability worldwide, with low back pain being the leading cause of disability in 160 countries. WHO has launched Rehabilitation 2030 Initiative to support countries to respond to existing rehabilitation needs, including people with musculoskeletal conditions, as well as the forecasted increase arising from health and demographic trends.